The Lipids Optimisation Point of Care Testing (POCT) project will focus on delivering POCT for cholesterol, within the social community settings that people regularly attend and communicate results through an integrated digital platform directly to primary care colleagues for action.

A key aim of the project will be to identify and reduce health inequalities in the outcomes of those Greater Manchester people at high cardiovascular risk through innovative approaches using data, diagnostics, and patient engagement.

The project will target areas in Manchester Locality at high risk of CVD and use creative approaches to co-design work with community and voluntary sector groups, build trust and raise awareness and promoting engagement and co-ownership.

We aim to understand and evaluate community enablers and address barriers to understand how we use diagnostics to ensure high risk community patients are referred earlier and managed in the care pathway to reduce the risk of cardiovascular disease.

This project is delivered as part of a series of projects that looks to address Greater Manchester’s major morbidities for the Advanced Diagnostics Accelerator (ADA), part of the Health Innovation Accelerator. The Health Innovation Accelerator has been established to rapidly improve the diagnosis and treatment of disease across the 2.8m Greater Manchester population.

Partners:

The Community Diagnostics – Lipid Optimisation project is delivered partnership by:

• Novartis (Co-Investor)
• Innovate UK (Co-Investor)

• Manchester Local Care Organisation (MLCO) (Project Management Partner)
• Northenden GP Practice (Clinical Oversight and logistics Partner)
• Manchester Winning Hearts & Minds & Public Health team (POCT Delivery Partner)
• BHA For Equality (POCT Delivery Partner)
• CAHN – Caribbean & African Health Network CIC (CAHN) (POCT Delivery Partner)
• MFT Lipidology Service (Partner)
• Aseem Mishra (GM CVD Prevention Oversight Group, Clinical Lead – Partner)
• Health Innovation Manchester (Project Management Partner)

The Health Innovation Accelerator

The Health Innovation Accelerator encompasses two projects, the Advanced Diagnostics Accelerator and the DEVOTE programme, delivered through a partnership between Health Innovation Manchester, Manchester University NHS Foundation Trust (MFT), The University of Manchester, and industry partners.

This project is part-funded by the Greater Manchester Innovation Accelerator programme. Led by Innovate UK on behalf of UK Research and Innovation, the pilot Innovation Accelerators programme is investing £100m in 26 transformative R&D projects to accelerate the growth of three high-potential innovation clusters – Glasgow City Region, Greater Manchester and West Midlands. Supporting the Government’s levelling-up agenda, this is a new model of R&D decision making that empowers local leaders to harness innovation in support of regional economic growth and help attract private R&D investment and develop future technologies.